Impaired monocyte activation in schizophrenia: ultrastructural abnormalities and increased IL-1β production

Natalya A Uranova1, P D Bonartsev2, L V Androsova3

  • 1Laboratory of Clinical Neuropathology, Mental Health Research Centre, Zagorodnoe Shosse 2, Moscow, 117152, Russia. uranovan@mail.ru.

Insights

Monocytes in individuals with schizophrenia show increased size and organelle content, alongside higher Interleukin-1 beta (IL-1β) production. These findings suggest heightened monocyte activation and altered cellular metabolism in schizophrenia patients.

Area of Science:

  • Neuroimmunology
  • Cellular Biology
  • Psychiatry

Background:

  • Monocyte activation is a known factor in schizophrenia (SZ).
  • Previous research indicates potential cellular alterations in SZ patients.

Purpose of the Study:

  • To investigate the ultrastructure of monocytes in drug-free schizophrenia patients.
  • To examine Interleukin-1 beta (IL-1β) production by monocytes in relation to cellular morphology.

Main Methods:

  • Electron microscopy and morphometry were used to analyze monocyte ultrastructure.
  • Enzyme-linked immunosorbent assay (ELISA) measured IL-1β production.
  • Statistical analyses included ANCOVA and Pearson correlation.

Main Results:

  • Schizophrenia patients exhibited significantly larger nucleoli, mitochondria, and lysosomes compared to controls.
  • Monocytes from schizophrenia patients produced higher levels of IL-1β.
  • IL-1β production correlated with lysosomal parameters in patients.

Conclusions:

  • Schizophrenia is associated with monocyte hyperactivity and altered intracellular organelle dynamics.
  • Disturbed metabolic interactions between lysosomes, mitochondria, and vacuoles may contribute to pathophysiology in schizophrenia.

Related Concept Videos

Biological Causes of Schizophrenia01:29

Biological Causes of Schizophrenia

Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
841
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders01:27

Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders

Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
2.3K
Psychological and Sociocultural Causes of Schizophrenia01:29

Psychological and Sociocultural Causes of Schizophrenia

Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
732